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ABSTRACT  
Objective: To evaluate the Antidiabetic & Antihyperlipidemic effect of Centratherum Anthelminticum (L) Kuntze extract against STZ induced 
diabetic rats. 
Methods: The present study examined the influence of Centratherum Anthelminticum extract (CASE), on blood glucose level and antioxidant 
enzymes level in STZ induced diabetic rats. The possible effects of chronic administration of the extract on the fasting serum glucose, insulin, 
and total cholesterol and triglycerides levels in STZ-induced diabetic rats were also evaluated. 
Results: The extracts showed a marked Antidiabetic & Antihyperlipidemic effect. Centratherum anthelminticum ethanolic seeds extract is 
capable of exhibiting glycemic control through its inhibitory effect on glycogenolytic enzyme glycogen phosphorylase, gluconeogenic enzymes 
such as glucose-6-phosphatase and fructose-1, 6-bis phosphatase and stimulatory effect on hexokinase, which is the key enzyme in the 
glycolytic pathway. 
Antihyperlipidemic activity of Centratherum anthelminticum ethanolic seeds extract proved by restoration of altered lipid profile 
Conclusions: The results of the study indicate that the extract of Centratherum anthelminticum possesses strong antidiabetic & 
antihyperlipidemic activity. This study also describes therapeutic effect of Centratherum anthelminticum in diabetes which will give a new 
direction for the future scientific research. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder with high blood 
sugar levels over a prolonged period of time. Symptoms of 
high blood sugar may be polyuria, polydipsia and polyphagia. 
Diabetes mellitus is a chronic metabolic disorder 
characterized by a high blood glucose concentration - 
hyperglycemia (fasting plasma glucose>126 mg/dL, or 
plasma glucose >200 mg/dL 2 hrs after a meal) - caused by 
insulin deficiency, often combined with insulin resistance. In 
diabetic patients, oxidative stress also has been found to be 
mainly due to increased production of oxygen free radicals 
and sharp reduction of anti-oxidant defense 1.  
Hypoinsulinemia associated with diabetes increased the 
activity of enzyme, fatty acyl Coenzyme A oxidase which 
initiates the β-oxidation of the fatty acids, resulting in lipid 
peroxidation. Increased lipid peroxidation impairs 
membrane function by decreased membrane fluidity and 
changing the activity of the membrane-bound enzyme and 
receptors 2. Its products (lipid radices and lipid peroxides) 
are harmful to the cell in the body and associated with 
atherosclerosis and brain damage. Diabetes Mellitus is 
associated with abnormalities in carbohydrates and lipid 
metabolism that results in excessive production of reactive 
oxygen species [ROS] and oxidative stress 3. 
Therefore the present study is undertaken to evaluate anti-
diabetic and anti-oxidant activity of C. anthelminticum in STZ 
induced diabetic rats.  
The ethnobotanical information reports about 800 plants 
that may possess antidiabetic potential. Folk medicine for 
diabetes from Rayalaseema reports 26 plants with 
antidiabetic activity. One such plant is C. anthelminticum 
synonyms; Vernonia anthelmintica, Conyza anthelmintica 
belongs to the family Asteraceae. In Hindi it is known as 
Kalizeeri 4. 
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Description of Plant 
\ 
Centratherum Anthelminticum (L) Kuntze plant and closed Seeds  
Ethno medicinal & traditional uses of different parts of 
Centratherum anthelminticum 
The Indications of Leaves of C. anthelmintic are rheumatism, 
chronic persistent fevers, phlegmatic cough, and dropsy. The 
indications of Seed of C. anthelmintic are kidney troubles, 
pustules, skin irritation, hiccough, eye itching, cold 
phlegmatic inflammation, chronic persistent fevers, dysuria, 
rheumatism, leucoderma, psoriasis, colic, vitiligo, sores, 
asthma, and pimples. 
Roots of C. anthelmintic are used in rheumatic swellings. 
Seed (powder) of C. anthelminticum is used in pimples, 
thread worms, irritative skin & round worms 5. 
Herb Paste of C. anthelminticum is used in skin eruptions, 
rheumatism. The Indications of infusion (seed) of C. 
anthelmintic are phlegmatic cough, dropsy, rheumatic 
affections, and chronic persistent fevers 6. 
Significance of the Study 
C. anthelminticum is an important drug of indigenous system 
of medicine and has been known for a number of medicinal 
properties in Ayurveda. C. anthelminticum is used as folk-
medicine for diabetes in Rayalaseema of Andhra Pradesh of 
India but still its pharmacological potential for anti-diabetic 
activity has not been fully explored 7. This study will try to 
provide scientific basis for the further development of 
antidiabetic activity of herbal drugs. 
MATERIAL AND METHOD 
 Collection & identification of plant material C. 
anthelminticum (L) kuntze. 
 Preparation of ethanolic extract of C. anthelminticum. 
The powdered seeds (200 g) are extracted with 1 l of 95% 
ethanol in a soxhlet extractor for 24 h. The solvent is 
recovered by distillation in vacuo which yielded a dark 
brown oily semisolid residue. The oil is separated from the 
extract on standing and the resultant extract is used for 
further studies 8. 
Chemicals and reagents 
STZ, RIA kit serum insulin level, GOD-POD kit serum glucose 
level, Glibenclamide, Ammonium thiocyanate, 1,1-diphenyl- 
2- picryl-hydrazyl (DPPHd), 3-(2-Pyridyl)-5,6-bis (4- phenyl-
sulfonic acid)-1,2,4-triazine (Ferrozine), Griess reagent, 
Colchicine, Ellman’s Reagent (DTNB), acetylthiocholine 
iodide, bovine serum albumin, thiobarbituric acid and 1, 1, 3, 
3-tetraethoxypropane (MDA) were purchased from Sigma 
chemical . Butylated hydroxytoluene (BHT), hydroxylamine, 
ferrous chloride, Ascorbic acid (Vitamin C), nitro blue 
tetrazolium, EDTA, β- carotene, Tween-80, trichloracetic acid 
(TCA), hematoxylin and eosin were purchased from Himedia 
Co. Chloral hydrate, isotonic saline, sodium carbonate, , 4% 
paraformaldehyde, paraffin, were purchased from Central 
Drug House Laboratory (CDH). All others unlabelled 
chemicals and reagents were analytical grade 9. 
Plant materials 
Fresh leaves and flowers of C. anthelminticum seed were 
collected from the khari baoli; chandni chowk Delhi .The 
plant was authenticated by Dr. Anjula Pandey , Principal 
Scientist National Herbarium of Cultivated Plants (NHCP) 
Division of Plants Exploration and Germplasm Collection, 
National Bureau of Plant Genetic Resources, New Delhi. The 
voucher specimen (NHCP/NBPGR/2018/39) of the plant 
material has been deposited in the Department.  
Preparation of ethanolic extract  
C. anthelminticum seed were dried under shade coarsely 
powdered and passed through 40 mesh sieves. Successive 
solvent extraction scheme was followed for the preparation 
of different extracts 10.  Coarsely powdered C. anthelminticum 
seed were defatted with petroleum ether using Soxhlet 
apparatus. The dried marc was further extracted with 
ethanol using Soxhlet apparatus. Solvent was removed under 
reduced pressure using rotary evaporator to yield dried 
ethanolic extract 11. 
Induction of diabetes & Experimental design 12 
Assessment of antihyperglycemic effect of ethanolic extract 
of C. anthelminticum seeds in normal and STZ induced 
diabetic rats:  
Body weights of the animals were recorded and they were 
divided into 7 groups of 6 animals each as follows 
Group I: Normal rats were administered with CMC 
Group II: Diabetic control - Rats were induced with 
Streptozotocin in normal   saline at a dose of 60 mg/ kg body 
weight IP. 
Group III: Groups of diabetic rats treated with ethanolic 
extract of C.A (100mg/kgbw) orally for 60 days  
Group IV: Groups of diabetic rats treated with ethanolic 
extract of C.A (200mg/kgbw) orally for 60 days  
Group V   : Groups of diabetic rats treated with ethanolic 
extract of C.A (300mg/kgbw) orally for 60 days  
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Group VI: Normal rats were administered orally the 
ethanolic extract of Centratherum anthelminticum 
(300mg/kgbw) for 60 days. 
Group VII: Groups of diabetic rats treated with 
Glibenclamide (5 mg/kgbw/oral) for 60 days  
Animal care and selection  
Adult male Swiss albino mice were obtained from the 
suitable source. They will be housed in polypropylene cages 
in groups of six mice per cage and kept in a room maintained 
at 25±2 °C with a 12-h light/dark cycle. They will be allowed 
to acclimatize for 1 week before the experiments and will be 
given free access to standard laboratory feed and water ad 
libitum. Protocol is approved by Institutional animal ethics 
committee.  
Acute toxicity study 
The acute toxicity study will be performed according to 
OECD guideline 423. The adult Albino Swiss mice 20-25 g 
will be randomly divided into five groups containing three 
animals in each group. The animals will be fasted overnight, 
and the C. anthelminticum seeds extracts will be 
administered orally of various dose levels (mg/kg, BW) 
suspended in 0.5% Carboxymethyl cellulose. Fifth group will 
be maintained as control and administered the vehicle only. 
The animals will be observed continuously for 2 h, then 
occasionally for a further 24 h, and finally any mortality. The 
behaviour of the animals and any other toxic symptoms will 
be observed for 72 h, and they were kept under observation 
for one week 13. 
Evaluation of Biochemical Parameters 
Estimation of serum glucose level (GOD-POD method), serum 
insulin level (RIA method), serum cholesterol (enzymatic 
method), HDL cholesterol (enzymatic method), serum 
triglyceride (enzymatic method), serum urea (Berthelot 
method) and creatinine (alkaline picrate method) has to 
done. VLDL-cholesterol and LDL- cholesterol are calculated 
as per Friedewald' equation 14. 
VLDL-cholesterol = total serum triglycerides/5 
LDL-cholesterol= Total serum cholesterol- total serum 
triglycerides/5-HDL-C 
Estimation of total cholesterol & triglyceride: 1.0 ml of 
isopropanol was mixed with 0.1 ml of sample and 0.1, 0.2, 
0.3, 0.4 and 0.5 ml of standard solution. To this 0.4g of 
alumina was added and mixed well for 15 min. The content 
was centrifuged at 3000 rpm for 10 minutes and 0.5 ml of 
the supernatant was transferred to reaction tubes and 
heated at 65 ºC for 15 min. Then 
0.6 ml of the saponification reagent was added and cooled. 
Then 1.0 ml of sodium metaperiodate and 0.5 ml of acetyl 
acetone reagent were added and heated at 65 ºC for 30 
minutes. The contents were cooled and the colour developed 
was read at 430nm. 
From the standard optical density values, the amount of 
triglyceride in the sample was calculated and expressed as 
mg/dl 15. 
Estimation of phospholipids 
0.1ml of sample (tissue lipid) was digested with 0.2ml of 
perchloric acid over a sand bath. Digestion was continued till 
it was colorless. The liberated phosphorus was estimated. 
4.3ml of deionised water was added to the digested sample 
followed by 0.5ml of ammonium molybdate. After 10min 
0.2ml of ANSA was added. Tubes were well shaken and kept 
aside for 20mins. Blue colour read at 620nm. The total 
phospholipids were estimated by multiplying the value of Pi 
by 25 and expressed as mg/g wet tissue 16. 
Estimation of HDL cholesterol  
To 1.0 ml of lipid extract, 0.18 ml of heparin manganese 
chloride reagent was added and mixed. This was allowed to 
stand in an ice bath for 30 minutes and then centrifuged in a 
refrigerated centrifuge 2500 g for 30 minutes. The 
supernatant contained HDL fraction. Aliquots of the HDL 
supernatant were estimated for cholesterol, phospholipids 
17. 
Estimation of VLDL 
To 1 ml of lipid extract was added to 0.15 ml of SDS solution. 
The contents were mixed well and incubated for 2 hours. The 
contents were centrifuged in a refrigerated centrifuge at 
10,000 g for 30 minutes. VLDL aggregated as a pellicle at the 
top. The supernatant was a mixture containing HDL and LDL 
fractions. The fractions of lipoproteins were assayed after 
heparin manganese chloride and SDS precipitation. The 
values are expressed in mg/dl plasma. After precipitation the 
cholesterol levels in supernatant was measured to get HDL 
cholesterol. SDS precipitated VLDL and the cholesterol 
content in the supernatant was measured for HDL 
cholesterol, LDL cholesterol and VLDL cholesterol 18. 
Evaluation of antioxidant Parameters 
Animal are scarified at the end of 28 days treatment. The 
liver of animal is dissected out, rinsed with ice cold distilled 
water followed by sucrose solution (0.25 M). One gm of liver 
tissue is homogenized in 10 ml ice cold Tris hydrochloride 
buffer. The prepared homogenates are centrifuged and used 
for the determination of antioxidant parameters like 
Malondialdehyde (MDA), Superoxide dismutase (SOD), 
catalase, Reduced Glutathione (GSH) levels and total protein 
estimation. Liver and kidney are isolated from one animal of 
each group and used for histopathology 19. 
Measurement of MDA i.e. lipid peroxidation, was measured 
spectrophotometrically by the method of using 1, 1, 3, 3-
tetraethoxypropane as standard. MDA is expressed as 
nanomoles per mg protein. GSH was determined by its 
reaction with 5, 5’-dithiobis (2-nitrobenzoic acid) 
(Ellman1959) to yield a yellow chromophore which was 
measured spectrophotometrically. GSH is expressed as µg/ 
mg protein 20. Nitrite is a stable end product of nitric oxide 
metabolism (as RNI) was measured in brain homogenate by 
Griess method. Briefly, the following procedure was adapted. 
The sample and reagents were well mixed and incubated for 
10 min at room temperature in dark. Then absorbance was 
taken at 540 nm. The concentration of nitrite in supernatant 
was determined from sodium nitrite standard curve 21. 
Histopathological studies 
For histopathological study, the tissues were fixed in Bouin’s 
fluid. The classical paraffin sectioning, and haematoxylin 
eosin staining techniques were used for histopathological 
studies. The various steps involved in the preparation of 
tissues for histopathological studies were: carried out 22. 
Statistical analysis 
The results are expressed as mean±S.E.M. Statistical analysis 
of passive avoidance, Morris water maze and biochemical 
values were performed by comparison Duncan’s multiple 
range test (DMRT). 
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RESULT AND DISCUSSION: 
Anti-diabetic activity of ethanolic leaves extract of 
Centratherum anthelminticum 
Effect of ethanolic leaves extract on Body weight, of 
experimental animals 
Body weights of the animals were recorded and they were 
divided into 7 groups of 6 animals each as follows 
Body weight 
The effect of administration of different doses (100, 200 and 
300mg/kg) of ethanolic leaves extract of Centratherum 
anthelminticum and Glibenclamide on body weight of rats 
during the experimental period is summarized on Table 4.15 
& Fig 4.10. Diabetes- induced animals showed significant 
decrease (p<0.05) in body weight day by day when 
compared with control animals. The ethanolic extract of 
Centratherum anthelminticum treated animals were found to 
be have significant increase (p<0.05) in body weight when 
compared with diabetes-induced animals. The results 
showed significant dose dependent increase in the body 
weight of the diabetic rats treated with the leaves extracts 
and the standard drug. The increase in ethanol extract 
treated group was similar to the normal group. There is no 
significant changes were observed in Centratherum 
anthelminticum alone (without induction of diabetes) treated 
rats 23. 
 
Table 1: Effect of ethanolic leaves extract on Body Weight of experimental animals 
 
Groups 
Body Weight(g) 
0th day 15th day 30th day 45th day 60th day 
I 180.00±3.33a 201.25±3.49 a 215.00±1.67 a 237.50±4.86 a 248.75±3.49 a 
II 187.50±3.91a 151.25±2.57 b 145.00±1.94 b 132.50±2.64 b 126.50±2.46 b 
III 
180.00±15.09 
a
 196.25±4.53 
a
 215.00±12.69 
a
 240.50±17.12 
a
 231.25±12.73 
a
 
IV 182.50±13.49 a 205.00±15.46 a 210.00±26.77 a 238.00±30.55 a 242.50±25.47 a 
V 185.00±12.69 a 210.00±10.74 a 220.50±20.10 a 235.00±20.28 a 245.50±28.94 a 
VI 186.00±11.06 a 202.00±11.73 a 160.00±18.56 a 230.50±16.46 a 238.00±21.21 a 
VII 185.00±2.36 a 200.00±13.49 a 204.50±20.38 a 217.50±21.95 a 240.00±21.86 a 
Values are expressed as Mean ± SD for six rats. Mean values within a graph followed by different letters are significantly 
different from each other at P <0.05 level comparison by Duncan’s multiple range test (DMRT) 
 
Fig 1: Effect of ethanolic seeds extract on Body Weight, of experimental animals 
Table 2: Effect of ethanolic seeds extract on Glucose (mg/dl) of experimental animals 
Groups Glucose (mg/dl) 
4th day 15th day 30th day 45th day 60th day 
I 106.40±1.62 a 103.60±0.68 a 103.75±0.66 a 103.75±0.66 a 104.00±0.66 a 
II 178.00±4.43 b 222.60±0.47 b 225.60±0.47 b 228.60±0.47 b 231.60±0.47 b 
III 151.00±5.85 c 212.45±0.34 c 207.45±0.34 c 202.45±0.34 c 197.45±0.34 c 
IV 142.00±2.33 c 207.95±0.34 c 199.95±0.34 c 191.95±0.34 c 183.95±0.34 c 
V 
114.00±2.71 
a
 103.95±0.34 
a
 102.70±0.34 
a
 117.70±0.34 
a
 118.70±0.34 
a
 
VI 107.60±1.57 a 103.45±0.68 a 103.60±0.66 a 104.23±0.66 a 104.35±0.66 a 
VII 
106.40±1.62 
a
 108.35±0.34 
a
 106.45±0.34 
a
 114.45±0.34 
a
 122.45±0.34 
a
 
Values are expressed as Mean ± SD for six rats. Mean values within a graph followed by different letters are significantly 
different from each other at P <0.05 level comparison by Duncan’s multiple range test (DMRT) 
Goutam et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2020; 10(2-s):140-148 
ISSN: 2250-1177                                                                                  [144]                                                                                 CODEN (USA): JDDTAO 
Effect of Centratherum anthelminticum ethanolic seeds 
extract on HDL, LDL, VLDL, FFA, PL and TC of 
experimental animals. 
Total cholesterol (TC), Triglycerides (G), Phospholipids (PL), 
free fatty acid (FFA), Low Density Lipoprotein (LDL), High 
Density Lipoprotein (HDL) and Very Low Density 
Lipoprotein (VLDL) content was shown in Table 4.18 and Fig 
4.14. Streptozotocin induced diabetic rats showed increased 
LDL (245.57mg/dl), TG (353.60mg/dl), VLDL (78.93mg/dl), 
FFA (2.77mg/dl), PL (1.96mg/dl), TC (392.00mg/dl) while 
decreased HDL (26.60mg/DL) content was observed 
24.Administration of different doses (100, 200 and 300mgkg) 
of ethanolic leaf extract of Centratherum anthelminticum 
decreased content in LDL, TC, VLDL, FFA, PL, TC and 
increased HDL content was observed dose dependent 
manner. Among the various doses, the highest dose 
(300mg/kg) of leaf extract of Centratherum anthelminticum 
shows significantly (p>0.05) restored the LDL (89.90mg/dl), 
TG (80.21mg/dl), VLDL (23.93mg/dl), FFA (1.43mg/dl), PL 
(1.41mg/dl), TC (140.54mg/dl) and increased HDL 
(70.80mg/DL) content to normal rats 25. The standard 
treated group also decreased LDL, VLDL, FFA, TC while 
increased HDL content. Centratherum anthelminticum alone 
(300mg/kg) treated rats did not show any significant 
variation in lipid profile throughout the experimental period 
26.
 
Table 3: Effect of Centratherum anthelminticum ethanolic seeds extract on HDL, TG, LDL, VLDL, FFA, PL and TC of 
experimental animals 
Groups Total Cholesterol (mg/g) Triglycerides (mg/g) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl) 
I 136.40±1.65 a 62.00±0.65 a 77.20±0.93 a 39.00±7.87 a 10.33±2.07 a 
II 392.00±1.12b 353.60±1.31 b 26.60±0.98 b 245.57±49.12b 78.93±11.79b 
III 327.60±1.02 c 312.60±0.80 c 46.31±0.74 c 213.90±42.81c 62.10±10.42c 
IV 230.00±1.55 d 262.60±0.94 d 54.80±0.79 d 143.90±28.83d 43.77±8.75d 
V 140.54±0.98 a 73.60±1.10 a 70.80±0.67 a 89.90±18.02 a 23.93±4.79 a 
VI 138.60±1.77 a 80.21±0.94 a 77.80±0.79 a 68.73±13.90 a 20.27±4.06 a 
VII 144.00±1.98 a 72.80±5.10 a 81.80±0.34 a 44.70±9.15 a 7.13±1.69 a 
Values are expressed as Mean ± SD for six rats. Mean values within a graph followed by different letters are significantly 
different from each other at P <0.05 level comparison by Duncan’s multiple range test (DMRT) 
 
 
Fig 2: Effect of Centratherum anthelminticum ethanolic seeds extract on HDL, TG, LDL, VLDL, TC of experimental animals 
Effect of Centratherum anthelminticum ethanolic seeds 
extract on liver LPO, SOD, CAT, GPx, GST, GSH of 
experimental animals 27 
The lipid peroxidation (LPO) content, Superoxide dismutase 
(SOD), Catalase (CAT), Glutathione peroxidase (GPx), 
Glutathione S transferase (GST) activity, Reduced glutathione 
(GSH), Vitamin C and E content in liver was given in Table 
4.19 and Fig 4.15, 4.16 and 4.71. Streptozotocin induced 
diabetic rats showed increased LPO content while decreased 
in the activities of SOD, CAT, GPx, GST and content of GSH, 
Vitamin C and E was observed. Administration of different 
doses (100, 200 and 300mgkg) of ethanolic leaf extract of 
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Centratherum anthelminticum decreased LPO content while 
increased in the activities of SOD, CAT, GPx, GST and content 
of GSH, Vitamin C and E was observed in dose dependent 
manner 24. Among the various doses, the highest dose 
(300mg/kg) of leaf extract of Centratherum anthelminticum 
shows significantly (p>0.05) restored the LPO content, the 
activities of SOD, CAT, GPx, GST and content of GSH, Vitamin 
C and E content to normal rats 28. The standard treated group 
showed no significant changes were observed in antioxidant 
enzymes. Centratherum anthelminticum alone (300mg/kg) 
treated rats did not show any significant variation in 
antioxidant status throughout the experimental period 29. 
 
Table 4: Effect of Centratherum anthelminticum ethanolic seeds extract on liver LPO, SOD, CAT, GPx & GSH of 
experimental animals. 
 
Groups 
LPO (nmol 
MDA/mg protein) 
SOD (Liver) (U/mg 
protein) 
CAT (Liver) (U/mg 
protein) 
GPx (U/mg 
protein) 
GSH (μg/ g 
tissue) 
Group I 2.77±0.09 a 1600.53±4.51a 24.0±1.5 a 997.0±151.7a 48636.4±5.0a 
Group II 13.91±0.08b 825.67±2.69b 8.8±2.3b 434.5±251.6b 25776.0±1.7b 
Group III 10.05±0.06c 1186.00±10.97d 15.6±1.5c 584.5±234.6 d 32124.8±2.4c 
Group IV 7.47±0.21d 1362.53±13.00c 18.0±0.6 d 831.5±184.2c 39684.0±2.0d 
Group V 3.02±0.04a 1516.80±8.12 a 22.0±1.0 a 970.0±156.4 a 46418.7±1.0a 
Group VI 2.83±0.03 a 1599.33±6.59 a 23.0±0.7 a 995.5±151.6 a 47653.2±4.3a 
Group VII 3.23±0.07 a 1590.53±4.51 a 24.0±1.5 a 997.0±151.7 a 48614.3±2.0a 
Values are expressed as Mean ± SD for six rats Mean values within a graph followed by different letters are significantly 
different from each other at P <0.05 level comparison by Duncan’s multiple range test (DMRT) 
 
Effect of Centratherum anthelminticum on AST, ALT, ALP 
activities and Direct Bilurubin, Total Bilurubin, protein 
content of experimental animals 24 
The AST, ALT, ALP activities and direct bilurubin, total 
bilurubin, protein content was represented in normal and 
experimental rats represented in Table 4.20 and Fig 4.18. 
Streptozotocin induced diabetic rats showed significantly 
increased in the activities of AST, ALT, ALP and content of 
direct bilurubin, total bilurubin while decreased protein 
content was observed 30. Administration of different doses 
(100, 200 and 300mgkg) of ethanolic leaf extract of 
Centratherum anthelminticum significantly restored in the 
activities of AST, ALT, ALP and content of direct bilurubin, 
total bilurubin while increased protein content was observed 
in dose dependent manner 31. Among the various doses, the 
highest dose (300mg/kg) of leaf extract of Centratherum 
anthelminticum shows significantly (p>0.05) restored the 
activities of AST, ALT, ALP and content of direct bilurubin, 
total bilurubin and protein content to normal rats 32. The 
standard treated group showed no significant changes were 
observed in liver markers. Centratherum anthelminticum 
alone (300mg/kg) treated rats did not show any significant 
variation in liver marker enzymes throughout the 
experimental period 33. 
 
 
 
Fig 3: Effect of Centratherum anthelminticum on AST, ALT, ALP activities and Direct Bilurubin, Total Bilurubin, protein 
content of experimental animals 
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Histology of Liver 34 
Photomicrographs of normal liver showed well visualized 
architecture with predominant nucleus. Liver sections of 
streptozotocin induced diabetic rats showed marked 
structural alterations in the liver 35. The major alteration 
was periportal fatty infiltration, necrosis of hepatocytes 36. 
This damage was reversed and regeneration of parenchyma 
cells by the leaf extract of Centratherum anthelminticum 
(300mg/BW) and Glibenclamide treatments (plate.1) 
 
Histology of pancreas 37 
Photomicrographs of pancreas showed normal acini and 
normal cellular population in the islets of langerhans in 
pancreas of control rats 38. Pancreas sections of 
streptozotocin induced diabetic rats showed extensive 
damage to the islets of langerhans and reduced dimensions 
of islets 39. Photomicrograph of Pancreatic Islets of 
Streptozotocin induced rat treated with Centratherum 
anthelminticum (300mg/kg) and Glibenclamide (1mg/kgbw) 
showing regeneration of Islets of Langerhans, blood vessels 
and acinus (plate.2). 
 
 
Photomicrograph of normal  rat liver showing normal 
architecture 
 
Photomicrograph of STZ induced rat liver showing 
degeneration of Parenchyma cells 
 
Photomicrograph of liver section STZ induced rat 
treated with Centratherum anthelminticum 
(300mg/kgbw) showing regeneration of parenchyma 
cells 
 
Photomicrograph of liver section STZ induced rat 
treated with Glibenclamide (1 mg/kgbw) showing 
regeneration of parenchyma cells 
Plate.1: Histology of Liver in normal and experimental rats (40x Magnification) 
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Photomicrograph of pancreatic islet of normal rat 
showing normal islet of Langerhans, blood vessel and 
Acinus 
 
Photomicrograph of Pancreatic Islets of STZ induced 
rat showing degeneration of islet Langerhans, blood 
vessel and Acinus 
 
Photomicrograph of Pancreatic Islets of STZ induced 
rat treated with Centratherum anthelminticum 
(300mg/ kgbw) showing Regeneration of islet 
Langerhans, blood vessel and Acinus 
 
Photomicrograph of Pancreatic Islets of STZ induced 
rat treated with Glibenclamide (1 mg/ kgbw) showing 
Regeneration of islet Langerhans, blood vessel and 
Acinus 
Plate.2: Histology of pancreas in normal and experimental rats (40x Magnification) 
 
SUMMARY 
Overall, the experimental studies suggest that Centratherum 
anthelminticum ethanolic seeds extract has potential 
antioxidant and antidiabetic activity 40. This study is the first 
scientific report that provides convincing Phytochemical and 
ethno pharmacological evidence for the relevance of 
Centratherum anthelminticum, thus providing scientific 
validity to its traditional consumption by the local populace 
of south India. The antioxidant and antidiabetic activity of 
Centratherum anthelminticum ethanolic seeds might be 
present in bioactive compounds 41. 
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